A human ovarian small cell carcinoma line (BIN-67) expresses abundant calcitonin (CT) receptors (CTR) (143,000 per cell) that are coupled, to adenylate cyclase. The dissociation constants (Kd) for the CTRs on these BIN-67 cells is approximately 0.42 nM for salmon CT and approximately 4.6 nM for human CT. To clone a human CTR (hCTR), a BIN-67 cDNA library was screened using a cDNA probe from a porcine renal CTR (pCTR) that we recently cloned. One positive clone of 3,588 bp was identified. Transfection of this cDNA into COS cells resulted in expression of receptors with high affinity for salmon CT (Kd = approximately 0.44 nM) and for human CT (Kd = approximately 5.4 nM). The expressed hCTR was coupled to adenylate cyclase. Northern analysis with the hCTR cDNA probe indicated a single transcript of approximately 4.2 kb. The cloned cDNA encodes a putative peptide of 490 amino acids with seven potential transmembrane domains. The amino acid sequence of the hCTR is 73% identical to the pCTR, although the hCTR contains an insert of 16 amino acids between transmembrane domain I and II. The structural differences may account for observed differences in binding affinity between the porcine renal and human ovarian CTRs. The CTRs are closely related to the receptors for parathyroid hormoneparathyroid hormone-related peptide and secretin; these receptors comprise a 
Introduction
Calcitonin (CT)1 is a peptide hormone comprising 32 amino acids first identified as a hypocalcemic factor secreted by the parafollicular cells of the thyroid gland in response to elevations in serum calcium levels (1) . The hypocalcemic effect of CT is mediated predominantly by direct inhibition of osteoclast-mediated bone resorption (2, 3) , although CT also enhances renal calcium excretion (3, 4) . High affinity CT binding has been demonstrated in bone and kidney as well as other tissues, such as the central nervous system (5 ), testes and spermatozoa (6, 7) , placenta (8) , and lung (9) . The presence of calcitonin receptors (CTR) has also been reported in cells derived from lung ( 10) and breast ( 11 ) carcinomas, as well as certain lymphoid ( 12) and myeloid cell lines ( 13) . Although the physiological role of CT in many of these tissues has not been established, its actions clearly extend beyond calcium homeostasis ( 14) .
The unique ability of CT to inhibit osteoclast-mediated bone resorption has led to its use in the treatment of disorders of bone remodeling, including osteoporosis, Paget's disease of bone, and some forms of hypercalcemia of malignancy. In addition, CT has been used to treat pancreatitis ( 15 ) and peptic ulcer disease ( 16) and to produce centrally mediated analgesia ( 17) . It is possible that some of the pharmacological effects of CT may be indirect and attributable to the cross-reaction ofCT with receptors for other hormones that are structurally similar, such as a-or ,B-CT gene-related peptide (CGRP) ( 18, 19) or amylin (20). a-CGRP is a product ofthe CT gene produced by differential RNA slicing (21) . fl-CGRP is a product of a separate gene but differs from a-CGRP in only 3 of the 37 amino acids (21) (22) (23) . These related ligands most likely interact primarily with their own high affinity receptors to produce hormone-specific effects, but at very high concentrations may also cross-react with the receptors for the other peptides (18) (19) (20) .
We recently used an expression strategy to clone the cDNA for a CTR from LLC-PKj cells, a porcine renal epithelial cell line (24) . Transfection ofthe cDNA into COS cells resulted in expression of high affinity CTRs that were functionally coupled to adenylate cyclase. Although previous studies (25) (26) (27) indicated that the effects ofCT in most tissues are mediated via coupling to guanine nucleotide regulatory proteins (G proteins), analysis of the deduced amino acid sequence of the cloned porcine CTR (pCTR) revealed an unusual structure that was not similar to the sequences of other G protein-coupled receptors (receptors that transduce signals via G proteins and span the membrane seven times) available in the data bank at that time (24) . Subsequently, comparison ofthe pCTR with the recently cloned receptors for parathyroid hormonepeptide; PTHrp, PTH-related peptide; CAR, Dictyostelium discoideum cAMP receptor; bROD, bovine rhodopsin receptor; ,BAR, hamster f(-adrenergic receptor; PAM, accepted point mutation.
parathyroid hormone-related peptide (PTH-PTHrp) and secretin revealed an unexpected similarity in amino acid sequence and predicted receptor structure (24, 28, 29) . The unique structure of these related receptors suggests that they may represent examples of a new family of peptide-binding G protein-coupled receptors.
In this report we describe the cloning of a human CTR (hCTR) cDNA from a eukaryotic expression library prepared from an ovarian small cell carcinoma cell line . The BIN-67 cells had been shown to respond to CT with increases in content ofcellular cAMP (30) . We also describe the binding ofhuman and salmon CTs to the receptor on these cells and on COS cells transfected with the cloned human ovarian CTR cDNA. The functional analysis of the cloned hCTR after expression in COS cells confirms that its binding kinetics differ from those of the porcine renal receptor. Analysis of the deduced amino acid sequence predicted from the hCTR cDNA and comparison to the pCTR sequence provides potential insights into the structural basis for these differences. Comparison ofthe hCTR receptor sequence to protein sequences in the available data bases suggests that the receptors for CT may be evolutionarily related to a chemoattractant receptor from the primitive eukaryote, Dictyostelium discoideum (31) .
Methods
Cultured cells and tissue. The BIN-67 cell line was isolated from a trypsin digest of a metastatic pelvic nodule derived from a primary ovarian small cell carcinoma, a rare tumor composed of poorly differentiated cells of uncertain developmental origin (30, 32, 33) . The cultured cell line preserves the mixed character ofthe primary tumor with both large and small cell components. The BIN-67 cells respond to CT with increases in cAMP content (30) . These cells were maintained from frozen stock and cultured in DMEM supplemented with 20% (vol/vol) fetal calf serum (Sigma Chemical Co., St. Louis, MO) and enriched with 20% Ham's F12 medium (Sigma Chemical Co.), aspreviously described (30) . LLC-PK, cells were maintained from frozen stock of those strains originally described to be CT responsive (34) . T47D cells, a line derived from a human breast carcinoma that expresses CTRs (35, 36) (40) . The filters were washed briefly in 2X SSC, 0.2% SDS followed by extensive washing in 0.5X SSC, 0.2% SDS at 520C with multiple buffer changes. Autoradiography was performed using film (XAR-5; Eastman Kodak Co., Rochester, NY) exposed for 12 to 72 h at -70'C with an intensifying screen. Colonies that hybridized with the labeled restriction fragment probe on both filters from a matching filter pair were isolated from the original agar plate and the cloned plasmid DNA isolated from an overnight growth using alkaline lysis plasmid preparation procedures (40) . Positive clones were verified by an additional Southern hybridization of the cloned cDNA inserts after restriction enzyme digestion of plasmid polycloning sites and agarose electrophoresis (40 10 -fold higher than that of salmon CT (Fig. 1 B) . Measurement ofhormone binding using competition-dissociation analysis after incubation of BIN-67 cells with 251I-human CT in the presence of increasing concentrations of unlabeled salmon CT revealed an apparent 50% inhibitory concentration (IC50) of -0.6-0.7 nM (Fig. 2 A) . Parallel assays using 1251 human CT with increasing concentrations of unlabeled human CT confirmed the lower affinity for human CT (IC50 Cloning of the BIN-67 ovarian carcinoma hCTR cDNA. A 32P-labeled probe prepared from a restriction fragment of the pCTR cDNA was used to screen a size-fractionated BIN-67 cell cDNA library by colony hybridization. Approximately 55,000 colonies were transferred to nylon filters and screened to yield one positive clone that contained an insert of 3,588 bp. The functional characteristics of this putative hCTR cDNA clone were then examined after DEAE-Dextran/chloroquine transfection into COS-M6 cells that had previously been shown not to bind CT (24) . Gorn, Lin, Yamin, Auron, Flannery, Tapp, Manning, Lodish, Krane, and Goldring (Fig. 3) . Assuming 10% transfection efficiency (on the basis ofprevious estimations with the pCTR [24] ), the receptor number per transfected cell is -1.4 X 106. The apparent Kd for salmon CT in the transfected COS cells is -0.44 nM (Fig. 3 A) , similar to the Kd for salmon CT in the native BIN-67 cells (--0.42 nM, Fig. 1 A) . The Kd for human CT of the expressed hCTR is -5.4 nM (Fig. 3 B) , similar to that in the native BIN-67 cells ('-4.6 nM, Fig. 1 B) , and -10 times that for salmon CT. PTH An.
( Fig. 3 A and B ) and the pCTR (' 6 nM for salmon CT; reference 24) were calculated by Scatchard analysis. Characterization of hormone-induced cAMP responses in COS-M6 cells transfected with the hCTR cDNA. To determine ifthe hCTR cDNA encodes a CT-binding protein that could be coupled to adenylate cyclase, COS-M6 cells were transfected with the hCTR cDNA and then incubated with CT for 20 min in the presence of the phosphodiesterase inhibitor, IBMX. As shown in Fig. 4 B, there was an approximate fourfold increase in cAMP levels in cells transfected with the hCTR that were incubated with maximal stimulatory concentrations ofsalmon CT (range: -1.6-4.3-fold in five experiments). There was no increase in cAMP levels in COS-M6 cells mock-transfected with a fl-galactosidase cDNA that were incubated with salmon CT (Fig. 4 A) . PTH did not alter cAMP levels in the hCTRtransfected COS cells (Fig. 4 B) . As expected, isoproterenol, an agonist of the fl-adrenergic receptor, increased cAMP levels in the fl-galactosidase cDNA-transfected (control) (Fig. 4 A) as well as the hCTR-transfected COS cells (not shown).
Analysis ofthe CTR cDNA predicted amino acid sequence.
Analysis ofthe 3,588-bp sequence of the hCTR cDNA ( Fig. 5) reveals an open reading frame beginning at position 250 that encodes a putative peptide of 490 amino acids. Comparison of this deduced amino acid sequence to that of the pCTR reveals 73% identity and 89% similarity. The hCTR is eight amino acids longer than the pCTR. The hCTR cDNA contains an A majorarea ofdivergencebetween the human and porcine CTRs is in the intracellular loop between the first and second transmembrane hydrophobic domains where the hCTR contains an inserted sequence of 16 consecutive amino acids not found in the pCTR (amino acids 176-191 in the hCTR). This insert provides the hCTR with a longer intracellular loop between the first and second predicted transmembrane helices.
Searches of nucleic acid data banks (Genbank and European Molecular Biology Laboratory) and protein sequence databases (Genbank Translated Databases, PIR, and Swiss-Prot) identified the rat secretin receptor and the recently cloned PTH-PTHrp receptor as the only published sequences exhibiting high percentages of identity to both the hCTR and pCTR. A statistical analysis, using the BLAST network service to compare the hCTR with the other sequences in the database, also identified one distantly related protein possessing -21% identity and -47% similarity. This protein is the cAMP receptor (CAR) from the slime mold, D. discoideum, which gave a Highest Scoring Hit Extension of 73 histogram units (P = 0.024), compared to 163 units (P = 1.8 X 10-16) for the secretin receptor. CAR binds cAMP, which acts as a chemoattractant to induce aggregation and differentiation of individual D. discoideum cells into a primitive multicellular organism (31 ) . CAR is -19% identical to the PTH-PTHrp and secretin receptors. In contrast, the hCTR is 34% identical (58% similar) to the PTH-PTHrp receptor and 30% identical (54% similar) to the secretin receptor. The PTH-PTHrp and secretin receptors are even more closely related with -43% identity (see Fig.  6 ). In higher than the 12-20% identity found among the other principal families that comprise the superfamily of G protein-coupled receptors (42) .
Each of the closely related peptide-binding receptors for CT, PTH-PTHrp and secretin possess homologous signal peptide-like NH2-terminal domains. The six cysteines in the first extracellular domain of the hCTR and pCTR are conserved and require no gap insertions for their alignment. The positions of the five cysteines closest to the carboxy-terminal end are conserved in the PTH-PTHrp and CT receptors, but only four of these cysteines are conserved in the secretin receptor. In addition, two other extracellular cysteines are notably conserved at sites in the putative second and third extracellular domains of all three receptor types. Three of four potential N-linked glycosylation sites in the first extracellular domains are preserved in the hCTR and pCTR; the two sites closest to the carboxy terminal are also conserved in the CT and PTH PTHrp receptors. Only the N-linked glycosylation site of th hCTR nearest to the first transmembrane domain is preserve in the secretin receptor and this site is displaced one amino acid toward the NH2 terminus relative to the transmembrane do main. Despite these conserved extracellular glycosylation site and cysteine residues, the major areas of sequence divergence among these receptors are in the NH2-terminal extracellula and COOH-terminal cytoplasmic regions where gaps are re quired to align the CTR and secretin receptor sequences rela tive to the longer PTH-PTHrp sequence. The most strikingl3 conserved regions ofthese receptors, not surprisingly, lie in the membrane-spanning domains.
CAR is also most homologous to the hCTR in the trans membrane domains, with an optimal alignment (44) matching each of the seven transmembrane domains and several conserved discriminator residues (31, 50, 53) (Fig. 6 ). This cAMP receptor also shares regions of homology with members ol other G protein-coupled receptor families (31 ) . The most conserved region between the hCTR and CAR is an area of transmembrane domain IV around the universally conserved tryptophan (42) , which includes a conserved proline three residues carboxyl to the tryptophan. Over this region (hCTR residues 279-289), there are eight identical and two conserved amino acids in CAR. In this region ofthe hamster f3-adrenergic (f#AR) and bovine rhodopsin (bROD) receptors, only the tryptophan and a leucine are identical to the residues in hCTR or CAR and a gap is required for alignment (reference 31 and Fig. 6 ). Overall, CAR has approximately the same modest but significant degree ofidentity to the bROD receptor (21% ), for example, as it does to the hCTR (21%). A dendrogram shown in Fig. 7 depicts the phylogenetic and evolutionary relationships among the hCTR, pCTR, PTH-PTHrp receptor, secretin receptor, CAR, bROD and hamster ,3AR receptors. This scheme depicts the approximately equal distances between CAR and the bROD/,BAR receptors and between CAR and the CT receptors. This relationship suggests that CAR represents a phylogenetic branch point linking these receptor families to a remote common ancestor. The much closer, and therefore more certain, relationship among the CT, PTH-PTHrp, and secretin receptors is also shown.
RNA analysis. Northern analysis of mRNA from BIN-67 cells, LLC-PK, cells, and T47D cells is shown in Fig. 8 . Also included in Fig. 8 (lane 4) is mRNA from a human giant cell tumor ofbone. Giant cell tumors are characterized by the presence of large numbers of multinucleated giant cells, which express phenotypic features of osteoclasts, including CTRs (37). The analysis was performed on the same blot under conditions of moderately high stringency (wash conditions: 600C, 0.2x SSC). A single transcript of -4.2 kb was identified in each of these samples. The high levels of CTR mRNA in the porcine LLC-PK, cells (which express -3 x I05 CTRs per cell) (24) resulted in a labeled band of moderate intensity even though only 1 gg of polyA+-selected RNA was analyzed compared with 5 jig of RNA from the human cells and tissue. In the human samples, the abundance ofthe CTR mRNA was higher in the samples from the BIN-67 cells and the giant cell tumor than the T47D cells.
Discussion
We report here the presence of a high affinity CTR on cells from a human ovarian small cell carcinoma line, BIN-67, and the cloning of the cDNA for this CTR. Transfection of this cDNA into COS cells resulted in expression of a receptor that has hormone-binding kinetics similar to the native CTR and is functionally coupled to adenylate cyclase.
The hCTR has 73% identity to the pCTR (24 secretin is, therefore, consistent with the existence ofa separate G protein-coupled receptor family to which these proteins belong. These receptors are more distantly related to a CAR from the primitive eukaryote, D. discoideum (31 ) , which has 21% amino acid identity to the hCTR. CAR is also remotely related to other G protein-coupled receptor families (31 ) , suggesting that all of these receptor families may be linked to a remote common ancestor.
Although the receptors for CT, secretin, and PTH-PTHrp have little overall sequence identity to the other major G protein-coupled receptor families, they do share certain basic structural features and a few key residues characteristic of this protein superfamily (42) . Common features include aminoterminal potential N-linked glycosylation sites and a cysteine residue in the second and third extracellular domains. There is evidence that these two extracellular cysteines form a disulfide bond essential for ligand binding (43, 52) . These cysteines and some other key residues are also found in the D. discoideum CAR. The most conserved regions among the CT, PTHPTHrp, and secretin receptors (and to a lesser extent, the CAR) lie in the membrane spanning domains, which are notably different from the transmembrane domains of the other members of the G protein-coupled receptor superfamily.
The unique structural features of the CTR family of receptors could account for several ofthe unusual functional properties ofthese receptors. For example, the CT receptor may couple to at least two distinct G proteins, resulting in activation of different signal-transduction pathways (26, 27 ). In the LLC-PK, cells, differential G protein coupling to the CT receptor appears to be dependent upon the stage of the cell cycle (27). So far, Northern analysis using the hCTR cDNA indicates the presence ofa single transcript size in the cells from which RNA was probed.
Despite the highly conserved sequences of the two cloned CTRs there are differences in ligand-binding affinity to human CT and salmon CT. Binding affinity for salmon CT is higher for the hCTR than the pCTR when both receptor cDNAs are expressed in COS cells. The Kd values for both cloned CTRs fall within the range reported for the majority of CTRs naturally expressed on their native cells. Structural differences in these two receptors may account for the differing binding characteristics for salmon CT since the Kd values for the receptors in the transfected COS cells and in the native cells are indistinguishable. This suggests that coupling to different G proteins is not responsible for the observed differences in binding affinities of the two receptors. Possible regions ofstructural divergence that may relate to the differences in binding characteristics include the region between the predicted first and second transmembrane domains where the hCTR contains a 16-amino acid sequence not present in the pCTR. Presumably, the differences in binding affinities for human and salmon CT between the human and porcine CTRs also relate to the distinct structural features of the human and salmon CT ligands ( 14) .
Photo emulsion autoradiography performed on BIN-67 cells incubated with '25I-salmon CT shows these cells to be heterogeneous with respect to the expression of CT receptors. The larger cells that tend to spread out over the culture substrate express the CTR in greatest abundance (Goldring, S. and Gorn, A., unpublished). The function of CTRs in the BIN-67 ovarian carcinoma cells or in the ovary itself is unknown. The developmental origin ofthe BIN-67 carcinoma cells is also uncertain (30, 32, 33 
